Pathogenic and vaccine strains of Japanese encephalitis virus elicit different levels of human macrophage effector functions

Archives of Virology

Volumn 157, Issue 10, 2012, Pages 1905-1918

  Sooryanarain, Harini ^a   Sapkal, Gajanan N ^a   Gore, Milind M ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VIRUS;

EID: 84867141908     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1386-8     Document Type: Article

References (46)

1. Erlanger ET, Weiss S, Keiser J, Utzinger J, Wiedenmayer K (2009) Past, present, and future of Japanese Encephalitis. Emerg Infect Dis 15(1): 1-7.
2. Gore MM (2004) Japanese encephalitis virus: host-Virus interactions. In: Mishra AC (ed) NIV commemorative compendium, 1st edn. NIV, Pune, pp 357-405.
3. CDC JEV fact sheet. http://www. cdc. gov/ncidod/dvbid/jencephalitis/facts. htm.
4. Kumar P, Krishna DV, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V (2004) Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J Gen Virol 85: 471-482.
5. Solomon T (2004) Flavivirus encephalitis. N Engl J Med 351: 370-378.
6. Libraty HD, Nisalak A, Endy PT, Suntayakorn S, Vaughn WD, Innis LB (2002) Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 96: 173-178.
7. Yu YX, Zhang GM, Guo YP, Ao J, Li HM (1988) Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 39: 214-217.
8. Kumar R, Tripathi P, Rizvi A (2009) Effectiveness of one dose of SA 14-14-2 vaccine against Japanese Encephalitis. N Engl J Med 360: 1465-1466.
9. Eckels KH, Yu YX, Dubois DR, Marchette NJ, Trent DW, Johnson AJ (1988) Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA 14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6: 513-518.
10. Li Y, Yea J, Yanga X, Xua M, Chena L, Meia L, Zhua J, Liua X, Chena H, Cao S (2009) Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation. Vaccine 29: 855-862.
11. Woodson ES, Freiberg NA, Holbrook RM (2011) Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus. Virology 412: 188-195.
12. Aleyas GA, George AJ, Han WY, Rahman MM, Kim JS, Han BS, Kim SB, Kim K, Eo KS (2009) Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J Immunol 183: 2462-2474.
13. Mathur A, Bharadwaj M, Kulshreshtha R, Rawat S, Jain A, Chaturvedi UC (1988) Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol 69: 423-432.
14. Kedarnath N, Gore MM, Dayaraj C, Sathe SP, Ghosh NS (1986) Effect of various mitogens on the replication of Japanese encephalitis virus in human mononuclear leukocyte cultures. Indian J Med Res 84: 231-238.
15. Ellermann-Eriksen S (2005) Macrophages and cytokines in the early defense against herpes simplex virus. Virol J 2: 59. doi: 10. 1186/1743-422X-2-59.
16. King NJ, Getts RD, Getts TM, Rana S, Shrestha B, Kesson MA (2007) Immunopathology of flavivirus infections. Immunol Cell Biol 85: 33-42.
17. Dejnirattisai W, Duangchinda T, Lin LC, Vasanawathana S, Jones M, Jacobs M, Malasit P, Xu NX, Screaton G, Mongkolsapaya J (2008) A complex interplay among virus, dendritic cells T cells, and cytokines in dengue virus infections. J Immunol 181: 5865-5874.
18. Spaeth BG, Longman SR, Albert LM, Rice MC (2005) Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 202: 1179-1184.
19. Winter PM, Dung MN, Loan TH, Kneen R, Wills B, Thu TL, House D, White JN, Farrar JJ, Hart AC, Solomon T (2004) Proinflammatory cytokines and chemokines in humans with Japanese Encephalitis. J Infec Dis 190: 1618-1626.
20. Nasveld EP, Ebringer A, Elmes N, Bennett S, Yoksan S, Aaskov J, McCarthy K, Kanesathasan N, Meric C, Reid M (2010) Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine-randomized, double-blind, 5-year phase II study in healthy adults. Human Vaccines 6: 1-9.
21. Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ (2001) Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 75: 934-942.
22. Pichyangkul S, Endy PT, Kalayanarooj S, Nisalak A, Yongvanitchit K, Green S, Rothman LA, Ennis AF, Libraty HD (2003) A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol 171: 5571-5578.
23. Aguilar PV, Paessler S, Carrara SA, Baron S, Poast J, Wang E, Moncayo CA, Anishchenko M, Watts D, Tesh BR, Weaver CS (2005) Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol 79: 11300-11310.
24. Liang JJ, Liao LC, Liao TJ, Lee LY, Lin LY (2009) A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine 27: 2746-2754.
25. Akaike T, Maeda H (2000) Nitric oxide and virus infection. Immunology 101: 300-308.
26. Johnson RT, Burke DS, Elwell M, Leake CJ, Nisalak A, Hoke CH, Lorsomrudee W (1985) Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18: 567-573.
27. Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, Grau EG (1997) Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 51: 132-136.
28. Ye C, Abraham S, Wu H, Shankar P, Manjunath N (2011) Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. PLoS One 6(3): e17889. doi: 10. 1371/journal. pone. 0017889.
29. Hase T, Dubois RD, Summers LP, Downs BM, Ussery AM (1993) Comparison of replication rates and pathogenicities between the SA 14 parent and SA 14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons. Arch Virol 130: 131-143.
30. Ni H, Chang JG, Xie H, Trent WD, Barrett A (1995) Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol 76: 409-413.
31. Nitayaphan S, Grant AJ, Chang JG, Trent WD (1990) Nucleotide sequence of the virulent SA- 14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA14-14-2. Virology 177: 541-552.
32. Lee E, Lobigs M (2002) Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76: 4901-4911.
33. Wang T, Town T, Alexopoulou L, Anderson FJ, Fikrig E, Flavell AR (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10: 1366-1373.
34. Wang PJ, Liu P, Latz E, Golenbock TD, Finberg WR, Libraty HD (2006) Flavivirus activation of plasmocytoid dentritic cells delinates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177: 7114-7121.
35. Cao S, Li Y, Ye J, Yang X, Chen L, Liu X, Chen H (2011) Japanese Encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells. Virol J 8: 39.
36. Hsu CT, Gao QJ, Lu HK, Tsai HC, Huang YC, Tzang SB (2008) Japanese encephalitis virus envelope protein mitigates TNF-alpha mRNA expression in RAW264. 7 cells. Inflammation 31: 133-140.
37. Arjona A, Ledizet M, Anthony K, Bonafé N, Modis Y, Town T, Fikrig E (2007) West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol 179: 8403-8409.
38. Samuel AM, Diamond SM (2005) Alpha/beta interferon protects against lethal west nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79: 13350-13361.
39. Diamond M, Roberts T, Edgil D, Lu B, Ernst J, Harris E (2000) Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74: 4957-4966.
40. Macejak D, Jensen K, Pavco P, Phipps K, Heinz B, Colacino J, Blatt L (2001) Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA. J Viral Hepat 8: 400-405.
41. Lin R, Liao C, Lin E, Lin LY (2004) Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78: 9285-9294.
42. Vrati S, Agarwal V, Malik P, Wani SA, Saini M (1999) Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J Gen Virol 80: 1665-1671.
43. Seitz C, Frensing T, Höper D, Kochs G, Reichl U (2010) High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol 91: 1754-1763.
44. Ashour J, Laurent-Rolle M, Shi PY, García-Sastre A (2009) NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83: 5408-5418.
45. Lin Y, Huang LY, Ma S, Yeh C, Chiou S, Chen L, Liao C (1997) Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 71: 5227-5235.
46. Pacher P, Beckman J, Liaudet L (2007) Nitric Oxide and Peroxynitrite in Health and Disease. Physiol Rev 87: 315-424.